Browsing Tag
AAVnerGene
2 posts
Klotho Neurosciences expands beyond the anti-aging gene with Turn Biotechnologies acquisition plan
Klotho Neurosciences moves to buy Turn Bio’s ERA and eTurna assets plus a $300M Korea pharma deal. Explore how this could reshape its longevity pipeline.
Klotho Neurosciences teams up with AAVnerGene to scale gene therapies for Alzheimer’s, ALS, and longevity
Klotho Neurosciences partners with AAVnerGene to accelerate AAV-based gene therapies for Alzheimer’s, ALS, and aging; aims for lower cost and higher precision.